The NK cell therapy is being trialled in combination with monoclonal antibody therapy and hopes to induce B-cell depletion.

Discover how 10x Genomics' spatial technologies are revolutionising the study of immunotherapies in solid tumors

Microbiome-based precision oncology offers promising cancer treatment possibilities but requires clear regulations due to ethical concerns like patient safety and access. Collaboration among stakeholders is essential to balance innovation and ethics effectively.

Cancer Immunotherapy Novel Targets and Immunotherapy are being finely tuned to optimise efficacy and minimise side effects, gradually becoming a standard, perhaps even predominant, method in cancer management.

The partnership aims to address unmet patient needs in the areas of immunology and cancer.

The AI model, called VGG16, analysed CT scans of the eyes of patients and achieved an accuracy of 94.27%.

Understanding the complex relationship between a pathogen and host response is important to developing effective vaccines and therapeutics to fight infectious disease.

Specialize in primary immune cells with a full panel of assay format (in vitro and ex vivo) on cells from different species, providing multiple optional readouts.

Insights on antigen-specific immunotherapy and the immunomodulatory functions of therapeutic chaperones at Immuno UK 2022.

On-Demand Webinar featuring Dr Darragh Duffy, LabEx Coordinator at Institut Pasteur

Our panel discussion brings together experts in immunology: discussing the key areas of autoimmunity, oncology, and COVID-19.

Bringing together the experts to discuss the timeline of autoimmune disease therapeutics.

Experts discuss elusively successful therapies and the rising costs that come with new technologies.

RevoloBio’s autoimmunity drug, ‘1805, breaks with the mould in its revolutionary approach. With success in a Phase II clinical trial, scientists wonder what’s around the corner for the field.